elder law weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of elder law weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Avanir Pharmaceuticals
Pharmaceutical firm announces $25M underwritten stock offering
June 23rd, 2004
Avanir Pharmaceuticals (AVN) announced the pricing of an underwritten offering of 19,685,040 shares of Class A common stock at a price of $1.27 per share. The gross proceeds of the offering are expected to be approximately $25 million. The offering is being made pursuant to a shelf registration statement on Form S-3 that was declared effective by the U.S. Securities and Exchange Commission. Avanir has granted the underwriter a 30-day option to purchase an additional 2,952,756 shares to cover over-allotments. All the shares are being sold by Avanir. The offering is expected to close June 1, 2004. Lazard Freres & Co., L.L.C., acted...
Source: elder law weekly (2004-06-23)
|
